An Interaction with Ewing’s Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer
Cell Reports, ISSN: 2211-1247, Vol: 17, Issue: 5, Page: 1289-1301
2016
- 36Citations
- 49Captures
- 6Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations36
- Citation Indexes36
- 36
- CrossRef21
- Captures49
- Readers49
- 49
- Mentions6
- News Mentions6
- 6
Most Recent News
IU research finds link between molecular mechanisms in prostate cancer and Ewing's sarcoma 27 Oct 2016
Gene link could mean children suffering from rare cancerous tumor may respond to future prostate cancer treatments. Medical researchers at Indiana University Bloomington have found
Article Description
More than 50% of prostate tumors have a chromosomal rearrangement resulting in aberrant expression of an oncogenic ETS family transcription factor. However, mechanisms that differentiate the function of oncogenic ETS factors expressed in prostate tumors from non-oncogenic ETS factors expressed in normal prostate are unknown. Here, we find that four oncogenic ETS (ERG, ETV1, ETV4, and ETV5), and no other ETS, interact with the Ewing’s sarcoma breakpoint protein, EWS. This EWS interaction was necessary and sufficient for oncogenic ETS functions including gene activation, cell migration, clonogenic survival, and transformation. Significantly, the EWS interacting region of ERG has no homology with that of ETV1, ETV4, and ETV5. Therefore, this finding may explain how divergent ETS factors have a common oncogenic function. Strikingly, EWS is fused to various ETS factors by the chromosome translocations that cause Ewing’s sarcoma. Therefore, these findings link oncogenic ETS function in both prostate cancer and Ewing’s sarcoma.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2211124716313705; http://dx.doi.org/10.1016/j.celrep.2016.10.001; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84994745776&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/27783944; https://linkinghub.elsevier.com/retrieve/pii/S2211124716313705; http://linkinghub.elsevier.com/retrieve/pii/S2211124716313705
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know